Skip to content

Prediction of depressive disorder based on EEG and metabolomics

Prediction of depressive disorder based on EEG and metabolomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091918
Enrollment
Unknown
Registered
2024-11-05
Start date
2020-07-07
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mood disorder(major depressive disorder/bipolar disorder)

Interventions

Gold Standard:ICD-10 Criteria for depressive episodes or bipolar depressive episodes
Index test:(1) Pre-processing of samples Plasma (urine) sample 100µl or fecal sample 50mg were taken, and 300µl methanol solution (containing 4µg/ml L-2-chlorophenylalanine as the internal standard) w
2-17min, 2%-95%B
17-19min, 95%B, Posttime: 6min. HILIC: Mobile phase: 10mM ammonium formate solution of A-0.1% formic acid, B acetonitrile solution containing 0.1% formic acid, sample size: 3ul, automatic injector tem

Sponsors

Zuowei Wang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients with depressive disorder: 1. Age 18-65 years old, gender unlimited; 2. Meeting the acute phase of ICD-10 depression or bipolar depression, HAMD-17 project =14 points; 3. Junior high school education or above, having enough audio-visual level and understanding ability to complete the necessary research examination; 4. Understanding the study content and sign the informed consent. Inclusion criteria for healthy controls 1. Age 18-65 years old, gender unlimited, matching with patients with depression disorder; 2. Junior high school education or above, having enough audio-visual level and understanding ability to complete the necessary research examination; 3. Understanding the study content and sign the informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients with depressive disorder 1. Currently suffering from severe and active physical disease (abnormal index > 2 times the normal value), or pharmacological conflict between current physical disease medication and antidepressant treatment; 2. Current risk of serious suicide (e.g., HAMD-17 item 3(suicide)=3 score); 3. Pregnant or lactating women, or those planning to become pregnant. Exclusion criteria for healthy controls 1. Currently suffering from mental illness; 2. Having a serious physical illness or disease that may interfere with the evaluation of the test; 3. Pregnant or lactating women, or those planning to become pregnant; 4. HAMD17 score > 7 or/and YMRS score > 10 when enrolled.

Design outcomes

Primary

MeasureTime frame
multiple reaction monitoring-mass spectrometry;Accuracy;Sensitivity;Specificity;

Secondary

MeasureTime frame
Positive predicative value;Negative predictive value;

Countries

China

Contacts

Public ContactZuowei Wang

Shanghai Hongkou Mental Health Center

wzwhk@163.com+86 180 0197 5178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026